LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,497,028 | +53.0% | 65,146 | +6.9% | 0.01% | +25.0% |
Q1 2023 | $2,938,527 | +107934.1% | 60,940 | +11.9% | 0.00% | 0.0% |
Q4 2022 | $2,720 | -99.9% | 54,482 | +12.3% | 0.00% | +33.3% |
Q3 2022 | $1,980,000 | -24.2% | 48,519 | +2.2% | 0.00% | -25.0% |
Q2 2022 | $2,612,000 | +45.1% | 47,481 | -4.2% | 0.00% | +100.0% |
Q1 2022 | $1,800,000 | -14.8% | 49,538 | +9.2% | 0.00% | 0.0% |
Q4 2021 | $2,113,000 | – | 45,344 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |